Immune Toxicities and Long Remission Duration after Ipilimumab Therapy for Metastatic Melanoma: Two Illustrative Cases
Abstract
Share and Cite
Assi, H.; Wilson, K.S. Immune Toxicities and Long Remission Duration after Ipilimumab Therapy for Metastatic Melanoma: Two Illustrative Cases. Curr. Oncol. 2013, 20, 165-169. https://doi.org/10.3747/co.20.1265
Assi H, Wilson KS. Immune Toxicities and Long Remission Duration after Ipilimumab Therapy for Metastatic Melanoma: Two Illustrative Cases. Current Oncology. 2013; 20(2):165-169. https://doi.org/10.3747/co.20.1265
Chicago/Turabian StyleAssi, H., and K.S. Wilson. 2013. "Immune Toxicities and Long Remission Duration after Ipilimumab Therapy for Metastatic Melanoma: Two Illustrative Cases" Current Oncology 20, no. 2: 165-169. https://doi.org/10.3747/co.20.1265